Figure 1From: Epigenetic regulation of CD133 and tumorigenicity of CD133 positive and negative endometrial cancer cellsCD133 is expressed in primary human endometrial tumors. Panel A shows the percentage of CD133+ cells in three independent primary human endometrial tumors (T1-T3) as determined by flow cytometry. Panel B is a representative flow cytometric analysis of the T3 primary endometrioid tumor. CD133+ and matched IgG isotype stained populations are shown in panel B.Back to article page